Q3 snapshot: The IPO market shows fresh signs of improvement, but the biotech crunch continues to bitenews2023-10-02T13:43:43+00:00October 2nd, 2023|Endpoints News|
Providence launches Praia Health to help health systems maintain patient relationshipsnews2023-10-02T12:00:50+00:00October 2nd, 2023|Endpoints News|
FDA rejects Eli Lilly’s eczema drug lebrikizumab due to third-party manufacturing issues news2023-10-02T11:40:43+00:00October 2nd, 2023|Endpoints News|
Exclusive: Automata Technologies raises $40M to expand lab automation businessnews2023-10-02T11:33:38+00:00October 2nd, 2023|Endpoints News|
Infinity Pharmaceuticals files for Chapter 11 after layoffs, scrapped merger with MEI Pharmanews2023-10-02T11:04:31+00:00October 2nd, 2023|Endpoints News|
Atomwise CEO on AI in biotech, shifting focus to TYK2 drug and pipelinenews2023-10-02T11:00:48+00:00October 2nd, 2023|Endpoints News|
Syndax stops PhIII leukemia study early after menin inhibitor shows efficacy in challenging mutationnews2023-10-02T11:00:31+00:00October 2nd, 2023|Endpoints News|
Katalin Karikó, Drew Weissman win Nobel Prize for mRNA discoveriesnews2023-10-02T10:10:55+00:00October 2nd, 2023|Endpoints News|
Project NextGen enlists ex-Warp Speed vaccine leader’s biotech for Covid-19 antibodiesnews2023-10-02T08:29:38+00:00October 2nd, 2023|Endpoints News|
Taking pulse on private biotech funding; Q&A with Isomorphic Labs CEO; Research institutions rethinks dealmaking; and morenews2023-09-30T10:00:59+00:00September 30th, 2023|Endpoints News|
